Allstate (NYSE:ALL) Cut to Hold at HSBC

Allstate (NYSE:ALL – Get Free Report) was downgraded by HSBC from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, Marketbeat reports. They currently have a $271.00 price objective on the insurance provider’s stock. HSBC‘s price target suggests a potential upside of 1.30% from the stock’s current price.

Several other equities analysts have also issued reports on ALL. The Goldman Sachs Group decreased their target price on Allstate from $280.00 to $250.00 and set a “neutral” rating for the company in a research report on Thursday, October 1st. UBS Group increased their price target on shares of Allstate from $261.00 to $275.00 and gave the company a “neutral” rating in a research report on Monday, August 10th. Morgan Stanley cut their price target on shares of Allstate from $265.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 6th. Weiss Ratings raised shares of Allstate from a “buy (a)” rating to a “buy (a+)” rating in a research note on Thursday, October 29th. Finally, Citigroup decreased their price objective on shares of Allstate from $240.00 to $215.00 and set a “sell” rating for the company in a report on Friday, October 2nd. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $270.76.

Read Our Latest Stock Analysis on Allstate

Allstate Stock Down 0.6%

Shares of Allstate stock opened at $267.51 on Friday. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.24. Allstate has a 12 month low of $191.13 and a 12 month high of $281.11. The business has a fifty day simple moving average of $245.96 and a 200 day simple moving average of $229.53. The stock has a market cap of $67.64 billion, a PE ratio of 6.06, a price-to-earnings-growth ratio of 0.59 and a beta of 0.13.

Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The insurance provider reported $9.76 EPS for the quarter, beating analysts’ consensus estimates of $6.89 by $2.87. Allstate had a return on equity of 38.48% and a net margin of 16.57%. The business had revenue of $17.35 billion during the quarter, compared to the consensus estimate of $15.87 billion. During the same quarter in the prior year, the company posted $11.17 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. Research analysts predict that Allstate will post 36.21 EPS for the current year.

Insider Transactions at Allstate

In other Allstate news, COO Mario Rizzo sold 56,225 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the transaction, the chief operating officer directly owned 82,227 shares of the company’s stock, valued at approximately $21,747,396.96. The trade was a 40.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.55% of the company’s stock.

Hedge Funds Weigh In On Allstate

Institutional investors have recently modified their holdings of the business. Strategic Global Advisors LLC bought a new position in Allstate in the second quarter valued at approximately $11,680,000. OMERS ADMINISTRATION Corp bought a new stake in shares of Allstate during the second quarter worth $6,861,000. QRG Capital Management Inc. increased its position in shares of Allstate by 82.1% during the second quarter. QRG Capital Management Inc. now owns 94,687 shares of the insurance provider’s stock worth $22,427,000 after acquiring an additional 42,690 shares in the last quarter. Bank of America Corp DE bought a new stake in shares of Allstate during the second quarter worth $1,410,362,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of Allstate during the second quarter worth $42,409,000. Institutional investors own 76.47% of the company’s stock.

Key Stories Impacting Allstate

Here are the key news stories impacting Allstate this week:

  • Positive Sentiment: Allstate reported Q3 earnings of $9.76 per share, above analysts’ estimates, and adjusted net income of $2.5 billion. Growth in Protection Services and higher investment income helped offset catastrophe losses. ALL Q3 Earnings Beat on Protection Services Unit Strength
  • Positive Sentiment: Auto policies grew 3.4%, and management highlighted progress on AI, including plans for a personal agentic assistant launch in early 2027. Allstate Earnings Call Highlights Strong Growth and AI Progress
  • Negative Sentiment: Despite the quarterly beat, net income fell about 45% year over year as catastrophe losses rose. Allstate also faces a margin risk as underlying auto loss costs increase while average premiums decline. Allstate Q3 Net Income Drops About 45% on Higher Catastrophe Losses
  • Negative Sentiment: Barclays raised its price target to $228 but kept an “underweight” rating, indicating a cautious view. Unusually high put-option activity may also reflect hedging or bearish positioning, though it does not confirm a change in the outlook. Barclays stock recommendations

About Allstate

(Get Free Report)

Allstate Corp. (NYSE: ALL) is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.

The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.

Further Reading

Analyst Recommendations for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.